This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Masayuki Utsugi
Introduction
Masayuki Utsugi is a prominent inventor based in Osaka, Japan. He is known for his contributions to the field of artificial nucleic acids. His innovative work has led to the development of a unique compound that has potential applications in various scientific domains.
Latest Patents
Utsugi holds a patent for a novel bridged artificial nucleic acid known as ALNA. This invention provides a new type of oligomer that includes a compound represented by a specific general formula. The patent outlines the structure and potential uses of this artificial nucleic acid, which could have significant implications in biotechnology and medicine.
Career Highlights
Masayuki Utsugi is affiliated with Mitsubishi Tanabe Pharma Corporation, where he has been able to apply his expertise in the development of innovative pharmaceutical solutions. His work at the company has been instrumental in advancing research in artificial nucleic acids.
Collaborations
Utsugi has collaborated with notable colleagues such as Hiroaki Sawamoto and Shinji Kumagai. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.
Conclusion
Masayuki Utsugi's contributions to the field of artificial nucleic acids exemplify the spirit of innovation in modern science. His patent for ALNA represents a significant advancement that could lead to new breakthroughs in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile